//
Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective
Dual antiplatelet therapy: how, how long, and in which patients?
Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease
A Platelet Function Modulator of Thrombin Activation Is Causally Linked to Cardiovascular Disease and Affects PAR4 Receptor Signaling
Ticagrelor with or without Aspirin in High-Risk Patients after PCI
Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy
Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis
Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI